Emergence of Escherichia coli sequence type 131 clone carrying bla CTX-M genes in Guilan Province, Northern Iran
Open Access
- 7 October 2025
- journal article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (10) , e0227024
Abstract
Extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales complicate clinical management, as they are resistant to standard antibiotics and often necessitate intricate treatment plans. As a result, continuous monitoring is essential to prevent the spread of resistant strains and ensure effective treatment options are available. Enterobacterales are humans’ primary contributors to urinary tract infections (UTIs). Among these, Escherichia coli ( E. coli ) sequence type 131 (ST131), which carries β-lactamase genes with significant virulence potential, has been documented globally. E. coli ST131 mostly belongs to the serotypes O25 and O16 and is a well-defined subclone of the FimH30 and FimH30-Rx. We aimed to evaluate the impact of the ST131 clone carrying three β-lactamase genes—the bla CTX-M-1 , bla CTX-M-14 , and bla CTX-M-15 genes—in the antibiotic resistance pattern of ESBL-producing E. coli (ESBL-EC) from UTIs in Guilan, Iran. The phenotypic confirmatory disc diffusion test (PCDDT), according to CLSI recommendations, was utilized to detect ESBL production. The ESBL-EC isolates were screened for the ST131 clone using specific PCR of O25b, O16, H30, and H30-Rx. Out of the 107 ESBL-EC, 70 (65.4%) showed as ST131. Among the ST131 clones, the highest frequency belonged to the ST131-H30 (98.6%). Among the beta-lactam antibiotics, both the ST131 and non-ST131 groups exhibited complete resistance (100%) to cefotaxime, ampicillin, amoxicillin-clavulanate, cephalothin, cefixime, and ceftriaxone while demonstrating the greatest susceptibility to imipenem ( R = 0%). In the case of non-beta-lactam antibiotics, both groups showed significant resistance (approximately 91%) to nalidixic acid, while displaying the highest susceptibility to nitrofurantoin (up to 83%). Our study confirmed the dominance of the ST131 clone among the ESBL-EC and β-lactamase genes associated with the transmission of this pandemic clone. IMPORTANCE: Various antibiotic resistance and virulence genes highlight challenges in clinical management and emphasize the need for effective treatment strategies to reduce the risks associated with UTIs. Continuous research is essential to improve knowledge and create innovative approaches to tackle these urological conditions. Our study confirmed the predominance of genes related to the ST131 clone, including O25, O16, H30, and H30-Rx, among ESBL-EC. We found that the E. coli ST131 clone carried bla CTX-M-1 , bla CTX-M-14 , and bla CTX-M-15 and was expanded in our locale. The clones differed significantly in resistance, susceptibility, and relative susceptibility, only in antibiotic resistance in the case of nitrofurantoin ( P < 0.001). Combining resistance genes in the ST131 clone can facilitate its rapid and successful global spread.Keywords
This publication has 47 references indexed in Scilit:
- The impact of the ST131 clone on recurrent ESBL-producing E. coli urinary tract infection: a prospective comparative studyScientific Reports, 2022
- Molecular epidemiology of antibiotic-resistant genes and potent inhibitors against TEM, CTX-M-14, CTX-M-15, and SHV-1 proteins of Escherichia coli in district Peshawar, PakistanSaudi Journal of Biological Sciences, 2021
- Hospital-diagnosed infections with Escherichia coli clonal group ST131 are mostly acquired in the communityScientific Reports, 2021
- Recurrence of urinary tract infections with extended-spectrum β-lactamase-producing Escherichia coli caused by homologous strains among which clone ST131-O25b is dominantJournal of Global Antimicrobial Resistance, 2020
- Urinary tract infections: microbial pathogenesis, host–pathogen interactions and new treatment strategiesNature Reviews Microbiology, 2020
- The higher prevalence of extended spectrum beta-lactamases among Escherichia coli ST131 in Southeast Asia is driven by expansion of a single, locally prevalent subcloneScientific Reports, 2019
- Detection of O25b-ST131 clone, CTX-M-1 and CTX-M-15 genes via real-time PCR in Escherichia coli strains in patients with UTIs obtained from a university hospital in IstanbulJournal of Infection and Public Health, 2019
- Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from IranEuropean Journal of Clinical Microbiology & Infectious Diseases, 2017
- Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamasesInternational Journal of Antimicrobial Agents, 2013
- Comparison of CTX-M-14- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae isolates from patients with bacteremiaJournal of Infection, 2011